TechSeeking Alpha6 days ago
Zealand Pharma CEO Discusses ADA Obesity Data
1 min read
Zealand Pharma CEO Adam Steensberg presented at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 on June 9, 2026. Steensberg discussed positive ADA updates for survodutide and petrelintide, noting a shift in obesity treatment focus from maximum tolerated doses toward minimum effective doses.
Level
Hype check
Tap to vote and see what everyone thinks.
